EGFR 19-Del Up-Regulate Fn14, JAK/STAT Expression to Promote Non-Small Cell Lung Cancer Tumorigenesis

FENG Zheng,SUN Ying,ZHOU Yongan,WANG Xuejiao,WEN Miaomiao,XIA Jinghua,XING Hao,WANG Lei,LI Xiaofei,ZHANG Zhipei
DOI: https://doi.org/10.3978/j.issn.2095-6959.2016.11.005
2017-01-01
Abstract:Objective: To investigate the basic role of EGFR 19-Del in the progression of non-small cell lung cancer (NSCLC), the expression of Fn14, p-JAK1 and p-STAT1 were detected in NSCLC cell lines.Methods: The protein expression of Fn14, p-JAK1, p-STAT1 were detected using Western blot in HCC827, H1975 and H292 cell lines before or after EGFR TKI treatment.Results: Contrast to H1975 and H292 cell lines, the gene and protein expression of Fn14, p-JAK1, p-STAT1 were higher in HCC827 cell lines. The results showed that EGFR-TKI (geiftinib) can reduce Fn14, p-JAK1, p-STAT1 protein expression in HCC827 cell lines, but not in H292 cell lines. Conclusion: EGFR 19-Del might up-regulate Fn14, JAK/STAT expression to promote NSCLC carcinogenesis, and Fn14 maybe a new potential therapeutic target in NSCLC with EGFR 19-Del.
What problem does this paper attempt to address?